rhPDGF-BB-Enhanced Wound Matrix

recombinant human platelet-derived growth factor-BB (rhPDGF-BB)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rhPDGF-BB-Enhanced Wound Matrix, covering 2026-03-23 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating rhPDGF-BB-Enhanced Wound Matrix for Head and Neck Reconstruction [Phase 2]